BIIB — BiogenFREE
Price
$198.67
previous close
Median target
$222
across current calls
Implied return
+11.7%
median target vs. price
Coverage
32 analysts · 46 calls
current predictions
Consensus
28/16/2+26 net
Buy / Hold / Sell
Current analyst calls on BIIB
Sorted by implied return. Each row is one analyst's live rating and price target.
| Analyst | Score | Rank | Succ% | Ret% | Firm | Call | Target | Impl. return | Updated |
|---|---|---|---|---|---|---|---|---|---|
| Christopher Marai | – | – | – | Nomura | Buy | $392 | +97.3% | Feb 7, 2020 | |
| Morten Herholdt | – | – | – | HSBC | Buy | $342 | +72.1% | May 3, 2024 | |
| Robyn Karnauskas | – | – | – | Truist Securities | Buy | $340 | +71.1% | May 16, 2024 | |
| Jay Olson | – | – | – | Oppenheimer | Buy | $275 | +38.4% | Apr 1, 2026 | |
| Yatin Suneja | – | – | – | Guggenheim | Buy | $260 | +30.9% | Apr 30, 2026 | |
| Brian Skorney | – | – | – | Baird | Buy | $255 | +28.3% | May 2, 2025 | |
| Mohit Bansal | – | – | – | Wells Fargo | Buy | $250 | +25.8% | Apr 20, 2026 | |
| Mohit Bansal | – | – | – | Wells Fargo | Buy | $250 | +25.8% | May 14, 2026 | |
| Salveen Richter | – | – | – | Goldman Sachs | Buy | $250 | +25.8% | May 15, 2026 | |
| Ilya Zubkov | – | – | – | Freedom Capital Markets | Buy | $245 | +23.3% | May 1, 2026 | |
| Sumant Kulkarni | – | – | – | Canaccord Genuity | Buy | $245 | +23.3% | Apr 1, 2026 | |
| Sumant Kulkarni | – | – | – | Canaccord Genuity | Buy | $245 | +23.3% | May 15, 2026 | |
| Andrew Fein | – | – | – | HC Wainwright & Co. | Buy | $237 | +19.3% | Apr 2, 2026 | |
| Andrew Fein | – | – | – | HC Wainwright & Co. | Buy | $237 | +19.3% | May 14, 2026 | |
| David Amsellem | – | – | – | Piper Sandler | Buy | $225 | +13.3% | May 15, 2026 | |
| Michael Yee | – | – | – | UBS | Buy | $225 | +13.3% | Apr 22, 2026 | |
| Michael Yee | – | – | – | UBS | Buy | $225 | +13.3% | May 15, 2026 | |
| George Farmer | – | – | – | Scotiabank | Buy | $224 | +12.8% | Aug 1, 2025 | |
| George Farmer | – | – | – | Scotiabank | Buy | $224 | +12.8% | Feb 13, 2025 | |
| Brian Abrahams | – | – | – | RBC Capital | Buy | $222 | +11.7% | Apr 30, 2026 | |
| Brian Abrahams | – | – | – | RBC Capital | Buy | $222 | +11.7% | May 14, 2026 | |
| Phil Nadeau | – | – | – | TD Cowen | Buy | $215 | +8.2% | Feb 9, 2026 | |
| Phil Nadeau | – | – | – | TD Cowen | Buy | $215 | +8.2% | May 14, 2026 | |
| Andrew Tsai | – | – | – | Jefferies | Buy | $210 | +5.7% | Mar 12, 2026 | |
| Terence Flynn | – | – | – | Morgan Stanley | Hold | $206 | +3.7% | May 14, 2026 | |
| Jason Zemansky | – | – | – | B of A Securities | Hold | $203 | +2.2% | May 14, 2026 | |
| Geoff Meacham | – | – | – | Citigroup | Hold | $200 | +0.7% | May 1, 2026 | |
| Evan Seigerman | – | – | – | BMO Capital | Hold | $196 | -1.3% | Feb 9, 2026 | |
| Evan Seigerman | – | – | – | BMO Capital | Hold | $196 | -1.3% | May 14, 2026 | |
| Laura Chico | – | – | – | Wedbush | Hold | $196 | -1.3% | May 18, 2026 | |
| Andrew Fein | – | – | – | HC Wainwright & Co. | Buy | $194 | -2.4% | Aug 1, 2025 | |
| Andrew Tsai | – | – | – | Jefferies | Buy | $190 | -4.4% | Sep 25, 2025 | |
| Srikripa Devarakonda | – | – | – | Truist Securities | Hold | $189 | -4.9% | Apr 13, 2026 | |
| Chris Schott | – | – | – | J.P. Morgan | Hold | $185 | -6.9% | Apr 24, 2026 | |
| Emily Field | – | – | – | Barclays | Hold | $185 | -6.9% | Feb 20, 2026 | |
| Emily Field | – | – | – | Barclays | Hold | $185 | -6.9% | May 14, 2026 | |
| Morten Herholdt | – | – | – | HSBC | Sell | $150 | -24.5% | Mar 17, 2026 | |
| Rajesh Kumar | – | – | – | HSBC | Sell | $150 | -24.5% | Mar 17, 2026 | |
| Christopher Raymond | – | – | – | Raymond James | Hold | $115 | -42.1% | Apr 29, 2025 | |
| Ami Fadia | – | – | – | Needham | Hold | – | – | May 14, 2026 | |
| Danielle Brill | – | – | – | Truist Securities | Hold | – | – | May 15, 2026 | |
| Jasper Hellweg | – | – | – | Argus Research | Hold | – | – | Apr 4, 2025 | |
| Jasper Hellweg | – | – | – | Argus Research | Hold | – | – | Jan 9, 2026 | |
| Robyn Karnauskas | – | – | – | Truist Securities | Buy | – | – | Mar 27, 2024 | |
| Thomas Shrader | – | – | – | BTIG | Hold | – | – | Apr 20, 2026 | |
| Umer Raffat | – | – | – | Evercore ISI Group | Buy | – | – | May 15, 2026 |
Analyst track records are Premium — unlock every analyst's score, rank and success rate.
Implied return = price target ÷ yesterday's close − 1: the move the stock would make if the analyst's target were hit. These are forward-looking predictions, not realized returns. Only reliable-basis calls are included; the consensus figures above are computed from the calls in this table.